Is It Safe to Microdose Ozempic and GLP-1 Drugs?

Microdosing GLP-1 (glucagon-like peptide-1) agonist weight loss drugs involves taking smaller doses of semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound) than recommended by the U.S. Food and Drug Administration (FDA). While microdosing began as a do-it-yourself trend to help manage side effects or save money, it has been increasingly endorsed by doctors for a variety of reasons, from weight loss maintenance to enhancing longevity.

Beverly Tchang, MD, an endocrinologist and obesity specialist at NewYork-Presbyterian and Weill Cornell Medicine in New York City, instructs some of her patients to microdose to help balance side effects with weight loss goals. The technique, she says, can be both safe and effective — but only when used under medical supervision.

The Risks of Microdosing

“Microdosing is an off-label strategy that requires specific instructions that should be tailored to the individual,” says Dr. Tchang. “Errors in microdosing could result in ‘overdosing,’ where you might be exposed to much higher doses than intended.”

These risks are likely more serious when people use their medicine without the close cooperation of a doctor. Katherine Saunders, MD, an obesity physician at Weill Cornell Medicine and the cofounder of FlyteHealth worries that too many people are microdosing “for superficial or very experimental reasons,” she says. “I only really hear about microdosing when it comes to compounding medications, which we never recommend, or off-label use of GLP-1s for longevity, addiction, and other indications.”

Although many doctors are writing prescriptions for GLP-1 microdosing, experts are concerned that they may not always be acting scrupulously, especially when working with less-reputable online compounding pharmacies. Telehealth businesses and med spas sometimes feature pictures of lean adults in their promotional materials, for example, but researchers don’t yet know about the benefits and risks of GLP-1 drugs to people who are not overweight.

It is possible that, in the future, the FDA will approve very small GLP-1 doses to treat conditions for which these drugs are not currently approved, such as type 1 diabetes. In the meantime, however, experts warn against using GLP-1 medications this way, even in microdoses.

“These are powerful medications that need to be prescribed and managed by trained clinicians,” says Dr. Saunders.

DIY Microdosing

GLP-1 weight loss medications are available in different forms — injection pens, vials, and pills — each of which requires a different microdosing technique.

Injection Pens and Counting Clicks

Until recently, almost all of the GLP-1 weight loss drugs sold in the United States came in injection pens, disposable devices that combine a medication reservoir and a needle tip. The injection pens for Ozempic and Wegovy do not deliver the prescribed dose with a single touch of a button. Instead, users have to measure out the dose by rotating a wheel at the base of the pen. As the wheel turns, it clicks. An indicator window appears when the desired dose is ready to inject.

Social media is full of discussions regarding the technique of counting clicks. YouTube and TikTok have videos teaching how and why to count Ozempic clicks, and communities on Facebook and Reddit share “click charts,” handy reference images that show how much medicine each click dials up. Some of the advice comes straight from doctors and pharmacists with social media followings.

Dr. Tchang doesn’t recommend trusting a click chart. She teaches her patients the technique herself: “I do the math with them.”

Microdosing isn’t nearly as easy with Mounjaro and Zepbound injection pens, because these pens do not allow for click counting. Users can extract custom doses from the pen with a syringe, though Tchang does not recommend this practice.

Vials and Syringes

Less math is involved when GLP-1 medications are distributed in vials: The user draws up a certain dose directly with a marked syringe.

Compounding pharmacies that market microdosed GLP-1 medications for gradual weight loss, longevity, or other benefits typically provide their medications in a glass vial. Compounded GLP-1 drugs, though sometimes considered risky, are only available with a prescription. In these cases, a clinician will prescribe a particular dose that is below the FDA-approved amount.

Pills

In early 2026, the FDA approved a Wegovy pill, a once-daily oral semaglutide at 25 mg for adults with obesity or weight-related medical problems. The Wegovy pill joins a lower-dose oral semaglutide that was previously approved for the treatment of diabetes.

Although compounding pharmacies could, in theory, create their own microdose GLP-1 pills, it is unclear if these will become available. One of the largest compounders canceled plans to produce an off-brand semaglutide pill under pressure from the FDA and Wegovy’s manufacturer, Novo Nordisk.

Why Are People Microdosing?

Experts say that there are several reasons why people using semaglutide might want to microdose, some more legitimate than others.

Managing Side Effects

GLP-1 drugs can result in substantial gastrointestinal side effects, including diarrhea, nausea, and vomiting. Not everyone experiences these uncomfortable symptoms, but those who do tend to feel them most severely when they step up to a higher dose of the medicine.

Microdosing allows users to increase their doses in smaller amounts than the standard increments. “A patient might be cautious of increasing semaglutide from 0.25 to 0.5 mg, so we might discuss microdosing to achieve a dose in between,” says Tchang.

Other patients may be unable to tolerate the side effects of the standard starter dose, but microdosing allows them to begin at an even lower level. “Some of our patients are on tiny doses if they don’t need or don’t tolerate higher doses,” says Saunders.

Microdosing could also help people manage side effects temporarily in situations where gastrointestinal distress might spell disaster. If you are scheduled to take your shot before a wedding, job interview, vacation, or some other important event, microdosing might offer a good alternative to skipping Ozempic doses entirely.

Saving Money or Managing Supply Gaps

Microdosing first emerged as a strategy to cope with the past Ozempic and Wegovy shortages.

It takes months to gradually “step up” to the maximum dose of Ozempic or Wegovy. If a patient on a high dose of semaglutide cannot fill their prescription for a large injection pen, they may fear that they will have to go back to square one, the smallest starter dose, and lose months of progress.

Counting clicks to make a pen last longer during a shortage is a viable strategy, says Saunders. “If patients are unable to obtain their medication for a period of time due to a supply shortage, it’s always better to stay on whatever dose they can, instead of stopping the medication completely,” Saunders says.

Some people who do not require a maximum dose are also trying to save money by filling prescriptions for high-capacity pens and counting clicks to administer smaller doses.

Longevity and Other Speculative Benefits

Some compound pharmacies are now advertising microdosed GLP-1 drugs to boost longevity or as an anti-addiction treatment, among other benefits that have not yet been endorsed by the FDA. Though there may be some preliminary evidence that the medications offer such benefits, there is generally a lack of good evidence to support their use.

Maintaining Weight Loss

Some GLP-1 users who achieve their weight loss goals gradually dial down their dose by tiny amounts in the hope of saving money, building up a stockpile, or even having a more “normal” appetite without compromising their weight loss success.

Saunders warns against making such adjustments without the help of a doctor: “If someone with obesity has lost a significant amount of weight with a GLP-1 medication and they decide on their own to greatly reduce the dose of the medication, they’ll be at high risk of regaining. Medication dosage should never be adjusted without consulting the prescribing provider.”

The Takeaway

• GLP-1 microdosing has emerged as a technique to save money, maintain weight loss, or reduce side effects, but there isn’t much data supporting the practice.
• Compounding pharmacies have also begun to market microdosing regimens, often claiming speculative health benefits such as improved longevity or relief from addiction.
• Some doctors encourage their patients to microdose, but the technique has risks and should only be attempted under the close direction of a healthcare provider.